My Watchlist

Top Indices

Nasdaq Composite

SPX

My Portfolio

Rocket Pharmaceuticals, Inc. - Common Stock (NQ:RCKT)

3.780 +0.040 (+1.07%)

Streaming Delayed Price Updated: 4:00 PM EST, Feb 20, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

Headline News about Rocket Pharmaceuticals, Inc. - Common Stock

< Previous 1 2 3 4 5 6 Next >

Tesla To $175? Here Are 10 Other Price Target Changes For Friday ↗

December 23, 2022

Oppenheimer cut CarMax, Inc. (NYSE: KMX) price target from $100 to $75. . Oppenheimer analyst Brian Nagel maintained an Outperform rating on the stock. CarMax shares fell 1.3% to $56.47 in pre-market...

Via Benzinga

Why AMC Entertainment Shares Are Trading Lower By Around 13%? Here Are 59 Stocks Moving In Thursday's Mid-Day Session ↗

December 22, 2022

Gainers Core Scientific, Inc. (NASDAQ: CORZ) shares jumped 188% to $0.1471. Core Scientific shares dipped 75% on Wednesday after the company filed for Chapter 11 bankruptcy.

Via Benzinga

Where Rocket Pharmaceuticals Stands With Analysts ↗

December 06, 2022

Via Benzinga

Expert Ratings for Rocket Pharmaceuticals ↗

December 06, 2022

Via Benzinga

SVB Leerink Maintains Outperform Rating for Rocket Pharmaceuticals: Here's What You Need To Know ↗

December 06, 2022

Via Benzinga

Analyst Ratings for Rocket Pharmaceuticals ↗

September 30, 2022

Rocket Pharmaceuticals (NASDAQ:RCKT) has observed the following analyst ratings within the last quarter:

Via Benzinga

Nasdaq Down Over 3%; IsoPlexis Shares Spike Higher ↗

December 22, 2022

U.S. stocks traded lower midway through trading, with the Dow Jones dropping around 600 points on Thursday.

Via Benzinga

Dow Tumbles 300 Points; US Economy Expands 3.2% In Q3 ↗

December 22, 2022

U.S. stocks traded lower this morning, with the Dow Jones dropping over 300 points on Thursday.

Via Benzinga

12 Health Care Stocks Moving In Monday's Pre-Market Session ↗

November 28, 2022

Via Benzinga

Why DraftKings Shares Are Trading Lower By 5%; Here Are 24 Stocks Moving Premarket ↗

November 28, 2022

Gainers Talkspace, Inc. (NASDAQ: TALK) shares rose 48.3% to $0.89 in pre-market trading. Talkspace recently named Jon Cohen as CEO.

Via Benzinga

Analyst Ratings for Rocket Pharmaceuticals ↗

July 26, 2022

Rocket Pharmaceuticals (NASDAQ:RCKT) has observed the following analyst ratings within the last quarter:

Via Benzinga

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday ↗

November 28, 2022

Welcome back, trader! It's time to check out the biggest pre-market stock movers that traders will want to know about on Monday!

Via InvestorPlace

Why Inotiv Shares Dipped 57%; Here Are 76 Biggest Movers From Yesterday ↗

November 18, 2022

Gainers Satixfy Communications Ltd. (NYSE: SATX) jumped 96.4% to settle at $51.70 on Thursday.

Via Benzinga

This Stock Is Up 106% In 2022 And Analysts Love It, But Jim Cramer Says 'There's Too Much Political Risk' ↗

November 15, 2022

On CNBC’s "Mad Money Lightning Round," Jim Cramer said Rocket Pharmaceuticals Inc (NASDAQ: RCKT) is a "very early stage company that has a lot in the pipe. I tend to like these companies."

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For November 8, 2022 ↗

November 08, 2022

Upgrades

Via Benzinga

$20 Million Bet On Rocket Pharmaceuticals? 3 Stocks Insiders Are Buying ↗

October 12, 2022

Although US crude oil prices traded lower on Wednesday, there were a few notable insider trades.

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For November 1, 2022 ↗

November 01, 2022

Upgrades

Via Benzinga

Citigroup To $47? Plus This Analysts Predict $95 For Papa John's ↗

October 03, 2022

Goldman Sachs cut Citigroup Inc. (NYSE: C) price target from $54 to $47. Citigroup shares fell 0.4% to $41.51 in pre-market trading.

Via Benzinga

Coca-Cola Price Target Cut By This Analyst? Plus Rocket Pharmaceuticals Likely To Rally Around 306% ↗

October 03, 2022

Wells Fargo cut the price target on The Coca-Cola Company (NYSE: KO) from $72 to $66. Wells Fargo analyst Chris Carey maintained an Overweight rating on the stock. Coca-Cola shares rose 0.3% to $56.20...

Via Benzinga

Why F45 Training Shares Climbed 41%; Here Are 84 Biggest Movers From Friday ↗

October 03, 2022

Gainers FingerMotion, Inc. (NASDAQ: FNGR) gained 82.2% to close at $3.37.

Via Benzinga

Health Care Company Rocket Pharmaceuticals Announces Acquisition of Renovacor ↗

September 30, 2022

Rocket Pharmaceuticals (NASDAQ:RCKT) has announced an acquisition of Renovacor (AMEX:RCOR) that is expected to be completed in Q1 of 2023.

Via Benzinga

Why Is Renovacor (RCOR) Stock Up 18% Today? ↗

September 20, 2022

Renovacor (RCOR) stock is gaining on Tuesday after announcing that Rocket Pharmaceuticals (RCKT) is acquiring it in an all-stock deal.

Via InvestorPlace

Rocket Pharmaceuticals Buys Renovacor, Strengthening Position In Gene Therapies For Heart Diseases ↗

September 20, 2022

Via Benzinga

Rocket Pharmaceuticals Stock Scores Rising Relative Strength Upgrade ↗

August 11, 2022

On Thursday, Rocket Pharmaceuticals stock received an upgrade to its Relative Strength (RS) Rating, from 88 to 94.

Via Investor's Business Daily

Raymond James Maintains Outperform Rating for Rocket Pharmaceuticals: Here's What You Need To Know ↗

August 09, 2022

Raymond James has decided to maintain its Outperform rating of Rocket Pharmaceuticals (NASDAQ:RCKT) and raise its price target from $22.00 to $24.00. Shares of Rocket Pharmaceuticals are trading up...

Via Benzinga

Rocket Pharmaceuticals: Q2 Earnings Insights ↗

August 08, 2022

Rocket Pharmaceuticals (NASDAQ:RCKT) reported its Q2 earnings results on Monday, August 8, 2022 at 04:01 PM. Here's what investors need to know about the announcement.

Via Benzinga

Why Comera Life Sciences Shares Jumped 101%; Here Are 74 Biggest Movers From Yesterday ↗

September 14, 2022

Gainers Akero Therapeutics, Inc. (NASDAQ: AKRO) shares jumped 136.8% to settle at $29.05 on Tuesday after the company's Phase 2b HARMONY study met its primary endpoint for both the 50mg and 28mg EFX...

Via Benzinga

Why Jim Cramer Says This Stock Is 'Definitely A Buy' ↗

July 20, 2022

On CNBC’s "Mad Money Lightning Round," Jim Cramer said he is with Tellurian Inc. (NYSE: TELL).

Via Benzinga

Why Amazon, Microsoft, Apple Shares Are Trading Lower, Here Are 50 Stocks Moving In Tuesday's Mid-Day Session ↗

September 13, 2022

Gainers NeuroBo Pharmaceuticals, Inc. (NASDAQ: NRBO) jumped 186% to $47.69 as the stock started trading on a 1-for-30 reverse split basis.

Via Benzinga

Raymond James Initiates Coverage On This Stock With Bullish Pitch On Gene Therapies ↗

July 08, 2022

Raymond James initiated coverage on Rocket Pharmaceuticals Inc (NASDAQ: RCKT) with an Outperform rating with a $22 price target based on the positive view of RP-L102 and RP-L201 gene therapy programs...

Via Benzinga

< Previous 1 2 3 4 5 6 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.